Technology: COVID
Headquarters: Mainz, Rheinland-Pfalz, Germany
Last Funding Date: 2022-04-14
Total Funding: 1741003260.0
Investment Stage: N/A
Last Funding Type: Post-IPO Equity
Acquisitions Number: Made Acquisitions
Number Of Exists: N/A
Founded Date: 2008-01-01
Investors Number: 4
Industry: mRNA-based Cancer Vaccines
Employee Number: N/A
Estimated Revenue: $100M to $500M
Investor Type: N/A
Funding Status: IPO